Cargando…

Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes

OBJECTIVE: To investigate the effects of inflammation on perfusion regulation and brain volumes in type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 147 subjects (71 diabetic and 76 nondiabetic, aged 65.2 ± 8 years) were studied using 3T anatomical and continuous arterial spin labeling magnet...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Vera, Zhao, Peng, Manor, Brad, Sejdić, Ervin, Alsop, David, Abduljalil, Amir, Roberson, Paula K., Munshi, Medha, Novak, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198286/
https://www.ncbi.nlm.nih.gov/pubmed/21926285
http://dx.doi.org/10.2337/dc11-0969
_version_ 1782214406766067712
author Novak, Vera
Zhao, Peng
Manor, Brad
Sejdić, Ervin
Alsop, David
Abduljalil, Amir
Roberson, Paula K.
Munshi, Medha
Novak, Peter
author_facet Novak, Vera
Zhao, Peng
Manor, Brad
Sejdić, Ervin
Alsop, David
Abduljalil, Amir
Roberson, Paula K.
Munshi, Medha
Novak, Peter
author_sort Novak, Vera
collection PubMed
description OBJECTIVE: To investigate the effects of inflammation on perfusion regulation and brain volumes in type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 147 subjects (71 diabetic and 76 nondiabetic, aged 65.2 ± 8 years) were studied using 3T anatomical and continuous arterial spin labeling magnetic resonance imaging. Analysis focused on the relationship between serum soluble vascular and intercellular adhesion molecules (sVCAM and sICAM, respectively, both markers of endothelial integrity), regional vasoreactivity, and tissue volumes. RESULTS: Diabetic subjects had greater vasoconstriction reactivity, more atrophy, depression, and slower walking. Adhesion molecules were specifically related to gray matter atrophy (P = 0.04) and altered vasoreactivity (P = 0.03) in the diabetic and control groups. Regionally, sVCAM and sICAM were linked to exaggerated vasoconstriction, blunted vasodilatation, and increased cortical atrophy in the frontal, temporal, and parietal lobes (P = 0.04–0.003). sICAM correlated with worse functionality. CONCLUSIONS: Diabetes is associated with cortical atrophy, vasoconstriction, and worse performance. Adhesion molecules, as markers of vascular health, have been indicated to contribute to altered vasoregulation and atrophy.
format Online
Article
Text
id pubmed-3198286
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31982862012-11-01 Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes Novak, Vera Zhao, Peng Manor, Brad Sejdić, Ervin Alsop, David Abduljalil, Amir Roberson, Paula K. Munshi, Medha Novak, Peter Diabetes Care Original Research OBJECTIVE: To investigate the effects of inflammation on perfusion regulation and brain volumes in type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 147 subjects (71 diabetic and 76 nondiabetic, aged 65.2 ± 8 years) were studied using 3T anatomical and continuous arterial spin labeling magnetic resonance imaging. Analysis focused on the relationship between serum soluble vascular and intercellular adhesion molecules (sVCAM and sICAM, respectively, both markers of endothelial integrity), regional vasoreactivity, and tissue volumes. RESULTS: Diabetic subjects had greater vasoconstriction reactivity, more atrophy, depression, and slower walking. Adhesion molecules were specifically related to gray matter atrophy (P = 0.04) and altered vasoreactivity (P = 0.03) in the diabetic and control groups. Regionally, sVCAM and sICAM were linked to exaggerated vasoconstriction, blunted vasodilatation, and increased cortical atrophy in the frontal, temporal, and parietal lobes (P = 0.04–0.003). sICAM correlated with worse functionality. CONCLUSIONS: Diabetes is associated with cortical atrophy, vasoconstriction, and worse performance. Adhesion molecules, as markers of vascular health, have been indicated to contribute to altered vasoregulation and atrophy. American Diabetes Association 2011-11 2011-10-15 /pmc/articles/PMC3198286/ /pubmed/21926285 http://dx.doi.org/10.2337/dc11-0969 Text en © 2011 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details.
spellingShingle Original Research
Novak, Vera
Zhao, Peng
Manor, Brad
Sejdić, Ervin
Alsop, David
Abduljalil, Amir
Roberson, Paula K.
Munshi, Medha
Novak, Peter
Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
title Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
title_full Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
title_fullStr Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
title_full_unstemmed Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
title_short Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
title_sort adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198286/
https://www.ncbi.nlm.nih.gov/pubmed/21926285
http://dx.doi.org/10.2337/dc11-0969
work_keys_str_mv AT novakvera adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes
AT zhaopeng adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes
AT manorbrad adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes
AT sejdicervin adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes
AT alsopdavid adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes
AT abduljalilamir adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes
AT robersonpaulak adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes
AT munshimedha adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes
AT novakpeter adhesionmoleculesalteredvasoreactivityandbrainatrophyintype2diabetes